Contrea
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 12
About Contrea
a Contrea engages in the development and management of MediOS, a platform designed to link doctors and patients. This platform employs video technology to assist doctors in their routine explanations and offers patients visual medical information. Additionally, it alleviates the workload of medical professionals by automating pre-operative interviews and managing viewing logs. In January 2026, Contrea, Inc., Aflac Ventures Japan and Mizuho Bank. Contrea, Inc. primarily offers a healthcare communication platform known as MediOS. This innovative system bridges the gap between healthcare providers, such as doctors, nurses, and clerks, and patients, enhancing collaboration and improving overall care experiences. MediOS is designed to streamline workflows by allowing medical professionals to focus on their core responsibilities while facilitating effective communication with patients. Released as part of the company's strategic initiative to transform the healthcare landscape through informed consent processes, MediOS serves a diverse client base that includes hospitals and clinics across various regions.The revenue structure of Contrea, Inc. revolves around B2B transactions, with healthcare institutions subscribing to the MediOS platform for enhanced patient-provider communication. Clients engage with Contrea through subscription agreements, where they pay for access to the platform based on the level of service and the number of users within their institution. This transactional model allows healthcare providers to integrate MediOS into their daily operations effectively.In November 2021, Contrea, Inc. The company plans to utilize these funds to expand video content, develop a system for smoother user experience, and strengthen its sales and marketing strategy to reform doctors' working styles by 2024. Contrea is also looking to expand its market reach beyond Japan, although specific targeted regions have not been defined.
Who invested in Contrea
12 investors across 2 rounds
See all investors in Contrea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Contrea
Who invested in Contrea?
Contrea has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Contrea raised?
Contrea has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Contrea last raise money?
Contrea's most recent round on record is a Series A, in Jan 2026.
What does Contrea do?
a Contrea engages in the development and management of MediOS, a platform designed to link doctors and patients.
Where is Contrea headquartered?
Contrea is headquartered in Tokyo, Japan.
Which VCs invest in companies like Contrea?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Contrea's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Contrea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.